U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.7181C>T (p.Ser2394Leu) AND Ataxia-telangiectasia syndrome

Germline classification:
Likely pathogenic (3 submissions)
Last evaluated:
Mar 22, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000534806.22

Allele description [Variation Report for NM_000051.4(ATM):c.7181C>T (p.Ser2394Leu)]

NM_000051.4(ATM):c.7181C>T (p.Ser2394Leu)

Genes:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
C11orf65:chromosome 11 open reading frame 65 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.7181C>T (p.Ser2394Leu)
Other names:
p.S2394L:TCA>TTA
HGVS:
  • NC_000011.10:g.108329112C>T
  • NG_009830.1:g.111281C>T
  • NG_054724.1:g.145721G>A
  • NM_000051.4:c.7181C>TMANE SELECT
  • NM_001330368.2:c.641-20041G>A
  • NM_001351110.2:c.*38+6108G>A
  • NM_001351834.2:c.7181C>T
  • NP_000042.3:p.Ser2394Leu
  • NP_000042.3:p.Ser2394Leu
  • NP_001338763.1:p.Ser2394Leu
  • LRG_135t1:c.7181C>T
  • LRG_135:g.111281C>T
  • LRG_135p1:p.Ser2394Leu
  • NC_000011.9:g.108199839C>T
  • NM_000051.3:c.7181C>T
Protein change:
S2394L
Links:
dbSNP: rs587779861
NCBI 1000 Genomes Browser:
rs587779861
Molecular consequence:
  • NM_001330368.2:c.641-20041G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001351110.2:c.*38+6108G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000051.4:c.7181C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.7181C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Ataxia-telangiectasia syndrome (AT)
Synonyms:
Louis-Bar syndrome; Cerebello-oculocutaneous telangiectasia; Immunodeficiency with ataxia telangiectasia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008840; MedGen: C0004135; Orphanet: 100; OMIM: 208900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000622719Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 23, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV002080153Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Oct 30, 2020)
germlineclinical testing

SCV005039227Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Mar 22, 2024)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients.

Austen B, Barone G, Reiman A, Byrd PJ, Baker C, Starczynski J, Nobbs MC, Murphy RP, Enright H, Chaila E, Quinn J, Stankovic T, Pratt G, Taylor AM.

Br J Haematol. 2008 Sep;142(6):925-33. doi: 10.1111/j.1365-2141.2008.07281.x. Epub 2008 Jun 28.

PubMed [citation]
PMID:
18573109
See all PubMed Citations (8)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000622719.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 2394 of the ATM protein (p.Ser2394Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with ataxia-telangiectasia (PMID: 26677768). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 127437). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ATM function (PMID: 18573109, 19431188, 26677768). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002080153.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005039227.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

Variant summary: ATM c.7181C>T (p.Ser2394Leu) results in a non-conservative amino acid change located in the PIK-related kinase (IPR014009) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251332 control chromosomes. c.7181C>T has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with Ataxia-Telangiectasia (example, Lin_2015) and in settings of multigene panel testing for cancers (example, Susswein_2016). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in complete loss of ATM-kinase activity (Austen_2008). The following publications have been ascertained in the context of this evaluation (PMID: 18573109, 19431188, 31843900, 34848827, 26677768, 26681312, 33119476). ClinVar contains an entry for this variant (Variation ID: 127437). Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024